Investor Materials

Thumb Date Download

July 20, 2018 Corporate Presentation 1.11 MB

December 31, 2017 2017 Annual Report 3.18 MB

July 24, 2016 2016 Annual Report 4.75 MB

July 23, 2016 2015 Annual Report 5.24 MB

July 21, 2016 2014 Annual Report 2.13 MB

Recent News

Halozyme To Host Fourth Quarter And Full-Year 2018 Financial Results Webcast And Conference Call 02/07/19

argenx and Halozyme Enter Global Collaboration and License Agreement for ENHANZE® Technology 02/04/19

Halozyme Provides 2019 Pipeline Update And Financial Guidance At 37th Annual JP Morgan Healthcare Conference 01/09/19

Halozyme Therapeutics To Present At The 37th Annual J.P. Morgan Healthcare Conference 12/26/18

HALO (NASDAQ) $17.04 +0.50 +3.02% Volume: 649,439 Pricing delayed 20 minutes February 15, 2019

Al Kildani
Vice President, Investor Relations
& Corporate Communications
Phone: 858-704-8122
Email: akildani@halozyme.com
media@halozyme.com
ir@halozyme.com

You are now leaving Halozyme.com. Halozyme is not responsible for or endorses the content of the linked site.